CERS Chrystal Jensen sells $105K worth of shares
Mar 06, 2025, 5:31 AM
0.00%
What does CERS do
Cerus, headquartered in Concord, California, focuses on developing the INTERCEPT Blood System to enhance blood safety by reducing pathogens in transfusion blood components. The company employs 288 people and specializes in various blood products.
Chrystal Jensen sold 66,292 shares of CERS on 4 March at $1.59 per share, worth a total of $105K. They now own 465,198 CERS shares, or a 14% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.